Trials / Completed
CompletedNCT04673032
Radiofrequency (RF) Ablation Prospective Outcomes Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 298 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiofrequency Ablation | Radiofrequency Ablation for treatment of chronic pain |
Timeline
- Start date
- 2020-12-22
- Primary completion
- 2025-02-07
- Completion
- 2025-02-07
- First posted
- 2020-12-17
- Last updated
- 2026-04-15
- Results posted
- 2026-04-15
Locations
15 sites across 4 countries: United States, Belgium, Italy, Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04673032. Inclusion in this directory is not an endorsement.